HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Possible GABAergic modulation in the protective effect of allopregnanolone on sleep deprivation-induced anxiety-like behavior and oxidative damage in mice.

Abstract
Sleep is considered critical for maintaining physical and mental health. Sleep deprivation is a type of stress that affects the human population globally. Stress increases plasma levels of neurosteroids in the brain, which have potent effects on the GABAergic system. In the present study, we investigated the possible involvement of GABAergic modulation in the protective effect of allopregnanolone on sleep deprivation-induced anxiety-like behavior and oxidative damage in mice. Pretreatment with allopregnanolone (10 and 20 mg/kg i.p.) significantly improved locomotor activity, weight loss and anxiety-like behavior. Biochemically, allopregnanolone treatment significantly restored reduced glutathione and catalase activity and attenuated elevated lipid peroxidation and nitrite levels when compared with untreated 72-h sleep-deprived animals (P < 0.05). A combination of flumazenil (0.5 mg/kg) and picrotoxin (0.5 mg/kg) with allopregnanolone (10 mg/kg) antagonized the protective effect of allopregnanolone and caused further impairment in locomotor activity, anxiety-like behavior, weight loss and oxidative damage. However, muscimol (0.05 mg/kg) in combination with allopregnanolone (10 mg/kg) potentiated its behavioral and antioxidant effects. These effects were significant when compared with the effects of either agent alone (P < 0.05). The present study indicates that allopregnanolone induces its protective effect by GABAergic modulation at various recognition sites on the GABA-benzodiazepine receptor complex. It also suggests that allopregnanolone could be used in the management of sleep deprivation-induced anxiety-like behavior and related oxidative damage.
AuthorsA Singh, A Kumar
JournalMethods and findings in experimental and clinical pharmacology (Methods Find Exp Clin Pharmacol) Vol. 30 Issue 9 Pg. 681-9 (Nov 2008) ISSN: 0379-0355 [Print] Spain
PMID19229376 (Publication Type: Journal Article)
CopyrightCopyright 2008 Prous Science, S.A.U. or its licensors. All rights reserved.
Chemical References
  • GABA Agonists
  • GABA Antagonists
  • GABA Modulators
  • Neuroprotective Agents
  • Nitrites
  • Picrotoxin
  • Muscimol
  • Flumazenil
  • Pregnanolone
  • Catalase
  • Glutathione
Topics
  • Animals
  • Anxiety (etiology, prevention & control)
  • Behavior, Animal (drug effects)
  • Body Weight (drug effects)
  • Catalase (metabolism)
  • Dose-Response Relationship, Drug
  • Flumazenil (pharmacology)
  • GABA Agonists (pharmacology)
  • GABA Antagonists (pharmacology)
  • GABA Modulators (pharmacology)
  • Glutathione (metabolism)
  • Lipid Peroxidation
  • Male
  • Maze Learning (drug effects)
  • Mice
  • Motor Activity (drug effects)
  • Muscimol (pharmacology)
  • Neuroprotective Agents (pharmacology)
  • Nitrites (metabolism)
  • Oxidative Stress (drug effects)
  • Picrotoxin (pharmacology)
  • Pregnanolone (pharmacology)
  • Sleep Deprivation (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: